Frontiers in Pharmacology (Aug 2021)
Editorial: Targeting the Chemoattractant System in Inflammation
- Tadashi Hosoya,
- Dunai Cordelia,
- Dunai Cordelia,
- Benedict D. Michael,
- Benedict D. Michael,
- Benedict D. Michael,
- Chie Miyabe,
- Jun Nagai,
- Jun Nagai,
- Thomas T. Murooka,
- Yoshishige Miyabe
Affiliations
- Tadashi Hosoya
- Department of Rheumatology, Tokyo Medical and Dental University (TMDU), Liverpool, United Kingdom
- Dunai Cordelia
- Clinical Infection Microbiology and Immunology, Institute of Infection Ecology and Veterinary Sciences, University of Liverpool, Liverpool, United Kingdom
- Dunai Cordelia
- NIHR HPRU for Emerging and Zoonotic Infection, Liverpool, United Kingdom
- Benedict D. Michael
- Clinical Infection Microbiology and Immunology, Institute of Infection Ecology and Veterinary Sciences, University of Liverpool, Liverpool, United Kingdom
- Benedict D. Michael
- NIHR HPRU for Emerging and Zoonotic Infection, Liverpool, United Kingdom
- Benedict D. Michael
- The Walton Centre NHS Foundation Trust, Liverpool, United Kingdom
- Chie Miyabe
- Division of Dermatology, Tokyo Women’s Medical University, Chiba, Japan
- Jun Nagai
- Department of Medicine, Harvard Medical School, Boston, MA, United States
- Jun Nagai
- Division of Allergy and Clinical Immunology, Brigham and Women’s Hospital, Boston, MA, United States
- Thomas T. Murooka
- Department of Immunology, University of Manitoba, Winnipeg, MB, Canada
- Yoshishige Miyabe
- Department of Cell Biology, Nippon Medical School, Institute for Advanced Medical Sciences, Tokyo, Japan
- DOI
- https://doi.org/10.3389/fphar.2021.744290
- Journal volume & issue
-
Vol. 12
Abstract
No abstracts available.Keywords